Sanuwave Health rises after $5M payment related to patent sale

[Hemodialysis machine in an hospital ward.]
gyn9038/iStock via Getty Images

* Sanuwave (NASDAQ:SNWV [https://seekingalpha.com/symbol/SNWV]) shares rose after it announced that it has received a $5M cash payment from its third-party licensee in connection with the exercise of a previously granted acquisition option.
* The payment stems from an exclusive license and option agreement originally executed on March 6, 2024, between Sanuwave and a third-party licensee.
* Under that agreement [https://storage.googleapis.com/sec-files-1/15nYlRDPbBbngibwbgOh/be28cc6bdb4c5f8dd489d1f5e52f89e1/be28cc6bdb4c5f8dd489d1f5e52f89e1-file-1.pdf?v=1755877444689], Sanuwave granted the licensee exclusive rights to utilize a portfolio of patents focused on intravascular shockwave applications.
* In exchange for those rights and the option to acquire the patents outright, the licensee paid Sanuwave a one-time licensing fee of $2.5M.
* The stock is up 8% today.

MORE ON SANUWAVE HEALTH

* SANUWAVE Health, Inc. 2025 Q2 - Results - Earnings Call Presentation [https://seekingalpha.com/article/4811433-sanuwave-health-inc-2025-q2-results-earnings-call-presentation]
* SANUWAVE Health, Inc. (SNWV) Q2 2025 Earnings Call Transcript [https://seekingalpha.com/article/4811432-sanuwave-health-inc-snwv-q2-2025-earnings-call-transcript]
* Sanuwave: High Growth Wound Care Tech Primed For A Breakout [https://seekingalpha.com/article/4793914-sanuwave-high-growth-wound-care-tech-primed-for-a-breakout]
* SANUWAVE outlines Q3 revenue target of $12M–$12.7M as new applicator production nears launch [https://seekingalpha.com/news/4482851-sanuwave-outlines-q3-revenue-target-of-12m-12_7m-as-new-applicator-production-nears-launch]
* Seeking Alpha’s Quant Rating on SANUWAVE Health [https://seekingalpha.com/symbol/SNWV/ratings/quant-ratings]